This study provided insights into metabolic regulation associated with disrupted GPR10-NPFFR2 signaling, contributing to the development of potential therapeutic interventions for obesity-related issues. This evidence concerns the gene PRLHR and obesity due to melanocortin 4 receptor deficiency.